360° SearchNetwork Hot Spots Trends Time Series

Advanced Search Options >>

Synthes Inc

Type: Company

Name: Synthes Inc

Nationality: Switzerland

Web Address: http://www.synthes.com/

Fact Sheet: Fact Sheet for Synthes, Inc.

First reported 12 hours ago - Updated 10 hours ago - 1 reports

JOHNSON & JOHNSON: to Submit 10 New Product Filings by 2017

Johnson & Johnson (JNJ) unit Janssen Pharmaceutical Co. said it plans to submit more than 10 new product filings and more than 25 significant brand line extensions by 2017, which would amount to roughly the same number of new product filings it made in ... [Published 4 Traders - 12 hours ago]

Entities: Johnson & Johnson, Ibrutinib, Synthes Inc, China

First reported May 22 2013 - Updated 12 hours ago - 4 reports

Serono SA

Swiss billionaires create major biotech campus at former Serono site

Two Swiss billionaires--Ernesto Bertarelli and Hansjörg Wyss--have joined forces to buy out the former Merck Serono facility in Geneva, with ambitious plans to create a major collaboration on discovery work and translational research while offering a ... [Published FierceBiotech - May 22 2013]

Entities: Serono SA, Hansjörg Wyss, Biotechnology

First reported May 21 2013 - Updated May 21 2013 - 1 reports

Beyeler Foundation

Harvard Gets $125 Million Gift From One of Its Own

A Harvard Business School alumnus who gave the university its largest gift is making a second $125 million donation to the school to fund a bioengineering institute, Harvard reported today.Hansjörg Wyss, a Swiss philanthropist who’s among the world’s ... [Published BusinessWeek - May 21 2013]

Entities: Hansjörg Wyss, Harvard University, Beyeler Foundation, Wyss Institute, Synthes Inc

First reported May 21 2013 - Updated May 21 2013 - 2 reports

Harvard University

Swiss entrepreneur gives Harvard $125 million for bioengineering research inspired by nature

A Swiss entrepreneur has given Harvard University $125 million for the second time in five years, to support a multidisciplinary bioengineering research institute that bears his name.The first $125 million, provided to found the Wyss Institute for Biologically ... [Published Boston Globe - May 21 2013]

Entities: Harvard University, Wyss Institute, Entrepreneur

First reported May 21 2013 - Updated May 21 2013 - 1 reports

DePuy Inc

DePuy Synthes Hit With Patent Lawsuit

Globus Medical Inc. is suing two of Johnson & Johnson’s DePuy Synthes’ units over allegations the company’s Zero-P VA intervertebral fusion implant product willfully infringes on Globus’ spinal device patent, The suit was filed on May 15 against DePuy ... [Published ODT Mag - May 21 2013]

Entities: Synthes Inc, DePuy Inc, Patent

First reported May 21 2013 - Updated May 21 2013 - 1 reports

Johnson & Johnson

This Stock’s 24% Year-to-Date Gain Signaling a Buy Opportunity?

“Opportunity cost”—it’s a phrase used in microeconomic theory to denote the costs that are forgone by not having your resources in the highest returning assets.It is a phrase that’s pertinent to the stock market.Without question, I remain completely taken ... [Published Trefis - May 21 2013]

Entities: Johnson & Johnson, Stock Market, Synthes Inc, Dividend

First reported May 18 2013 - Updated May 18 2013 - 1 reports

Synthes Inc

MassDevice.com +7 | The top 7 med-tech stories for the week of May 13, 2013

Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com's coverage highlights our seven biggest and most influential stories from the week's news to make sure you're up to date ... [Published MassDevice - May 18 2013]

Entities: Synthes Inc, DePuy Inc, Globus Medical Inc

First reported May 17 2013 - Updated May 17 2013 - 1 reports

This Stock’s 24% Year-to-Date Gain Signaling a Buy Opportunity?

Entities: Johnson & Johnson, Stock Market, Parabola, Synthes Inc, Dividend

First reported May 17 2013 - Updated May 17 2013 - 1 reports

Patent Issued for Intervertebral Implant for Transforaminal Posterior Lumbar Interbody Fusion Procedure

(NewsRx) -- By a News Reporter-Staff News Editor at Biotech Business Week -- A patent by the inventors Messerli, Dominique (West Chester, PA); Gerber, David (Exton, PA); Paul, David (Phoenixville, PA); Kobayashi, Kenneth Isamu (Exton, PA), filed on March ... [Published NewsRX - May 17 2013]

Entities: Patent Issued, Paul David, Synthes Inc, Patent, DePuy Inc

First reported May 08 2013 - Updated May 08 2013 - 2 reports

Ceramax® Total Hip System With Biolox® Delta Ceramic-On-Ceramic 36mm Large Femoral Head Receives FDA PMA Supplement Approval

New Ceramic-on-Ceramic Option Provides Additional Choice within PINNACLE Hip Portfolio in the U.S.DePuy Orthopaedics, Inc. has received Pre-Market (PMA) Supplement Approval from the U.S. Food and Drug Administration (FDA) for the DePuy CERAMAX Total Hip ... [Published Medical News Today - May 08 2013]

Entities: DePuy Inc, Synthes Inc, Patient, Supplement

First reported May 03 2013 - Updated May 03 2013 - 2 reports

The New Abbott Labs Is Leaner, but Needs Better Execution

Tickers in this article: ABBV ABT JNJNEW YORK (TheStreet) -- Investors had mixed feelings when Abbott Labs decided to spin off its drug business to a new entity called AbbVie .While there were certainly logical reasons for breaking up the two companies, ... [Published Delco Times - May 03 2013]

Entities: Abbott Laboratories, Johnson & Johnson, AbbVie

First reported May 01 2013 - Updated May 01 2013 - 3 reports

Johnson & Johnson's Stock Looks Too Healthy TheStreet.com

The stock is already up more than 22% on the year and trading at a price/earnings ratio that is more than twice that of rival Abbott Laboratories Although Johnson & Johnson remains an undisputed force in health care, this has not been a flawless operation. ... [Published Yahoo! Finance - May 01 2013]

Entities: Johnson & Johnson, Synthes Inc, TheStreet.com

Quotes

"The Wyss Institute shall be a multidisciplinary Institute whose mission will be to develop biologically inspired solutions that will solve critical medical problems and to translate these transformative technologies into products that have an impact on society and the world" said Wyss, who created the Wyss Institute at Harvard

Swiss billionaires create major biotech campus at former Serono site [Published FierceBiotech - May 22 2013]

"This project constitutes a unique opportunity to increase research and development in the biotechnology sector of the Lake Geneva region and its related job creation" Patrick Aebischer, president of the Lausanne-based university known as EPFL by its French acronym, said in the statement

Swiss Billionaires Buy Merck Geneva Building for Biotech Campus [Published BusinessWeek - May 22 2013]

"Everybody loves New Jersey too much, so nobody is willing to go" Actavis CEO Paul Bisaro said when asked if there would be any management moving to Ireland. "There won't be any management relocation."

Actavis CEO: Ireland great for paying less tax, but "everybody loves New Jersey too much" to leave [Published Philadelphia Inquirer - May 22 2013]

"This landscape was broken in the Dust Bowl of the 1930s," Poole says. "Ranchers and the Soil Conservation Service worked and brought this prairie back. It’s not pristine; it’s restored. It doesn’t need to be saved from ranchers; it was already saved by ranchers."

Bison-Loving Billionaires Rile Ranchers With Western Land Grab [Published BusinessWeek - May 22 2013]

More Content

sort by: Date \| Relevance
JOHNSON & JOHNSON: to Submit 10 New Product Fil... [Published 4 Traders - 12 hours ago]
Johnson & Johnson: At The Crossroads - Part IV ... [Published Seeking Alpha - 14 hours ago]
Swiss billionaires create major biotech campus ... [Published FierceBiotech - May 22 2013]
Swiss Billionaires Buy Merck Serono HQ for Biot... [Published BioSpace - May 22 2013]
Swiss Billionaires Buy Merck Geneva Building fo... [Published BusinessWeek - May 22 2013]
Actavis CEO: Ireland great for paying less tax,... [Published Philadelphia Inquirer - May 22 2013]
Swiss billionaires buy Merck Serono HQ for biot... [Published Reuters via Yahoo! - May 22 2013]
Largest Donor to Harvard Doubles Gift to Wyss I... [Published Harvard Crimson - May 22 2013]
Bison-Loving Billionaires Rile Ranchers With We... [Published BusinessWeek - May 22 2013]
Harvard Gets $125 Million Gift From One of Its Own [Published BusinessWeek - May 21 2013]
Swiss entrepreneur gives Harvard $125 million f... [Published Boston Globe - May 21 2013]
DePuy Synthes Hit With Patent Lawsuit [Published ODT Mag - May 21 2013]
Harvard’s Largest Gift Doubles With Second Wyss... [Published Bloomberg - May 21 2013]
Sexual function in older adults with thoracolum... [Published EurekAlert! - May 21 2013]
This Stock’s 24% Year-to-Date Gain Signaling a ... [Published Trefis - May 21 2013]
Increasing Prevalence of Osteoarthritis and Pre... [Published Zecco - May 20 2013]
MassDevice.com +7 \| The top 7 med-tech stories ... [Published MassDevice - May 18 2013]
This Stock’s 24% Year-to-Date Gain Signaling a ... [Published Jutia Group - May 17 2013]
Patent Issued for Intervertebral Implant for Tr... [Published NewsRX - May 17 2013]
Globus Medical sues J&J's DePuy Synthes unit ov... [Published MassDevice - May 16 2013]
Johnson & Johnson: At The Crossroads - Part III [Published Seeking Alpha - May 16 2013]
Johnson & Johnson profits hit [Published Trinidad and Tobago's Newsday - May 16 2013]
Synthes warns of fragmentation risk with soft t... [Published MassDevice - May 14 2013]
Johnson & Johnson: An Investment In A Healthcar... [Published Seeking Alpha - May 13 2013]
Stock Buybacks: Smart vs. Not Smart [Published Yahoo! Finance - May 13 2013]
Is Johnson & Johnson Heading Off The Patent Cliff? [Published Seeking Alpha - May 13 2013]
Medical exchange program improving lives [Published Aspen Daily News - May 12 2013]
MediPoint: Total Ankle Replacement - US Analysi... [Published SBWire - May 11 2013]
Johnson & Johnson: At The Crossroads - Part II [Published Seeking Alpha - May 10 2013]
Medtronic: A Look At The Spinal Division [Published Trefis - May 10 2013]

Blogs

sort by: Date \| Relevance
Are Johnson & Johnson’s Recall Nightmares Over? [Published Wall St. Cheat Sheet - Apr 16 2013] From one perspective, Johnson & Johnson ( NYSE:JNJ ) showed great strength in its first quarter results. For the three month period, the company announced Tuesday that it had beat Wall Street’s quarterly profit estimates thanks to significantly lower ...
Are Johnson & Johnson’s Recall Nightmares Over? [Published Wall St. Cheat Sheet - Apr 16 2013] From one perspective, Johnson & Johnson ( NYSE:JNJ ) showed great strength in its first quarter results. For the three month period, the company announced Tuesday that it had beat Wall Street’s quarterly profit estimates thanks to significantly ...
Gorsky Gets A Haircut: J&J Cuts Executive Bonuses [Published Pharmalot - Mar 14 2013] Citing various ‘disappointments’ and a ‘mixed’ overall performance, Johnson & Johnson lowered the bonuses given to ceo Alex Gorsky and other top execs by 10 percent. The move comes after three years of scandals, manufacturing gaffes, an FDA consent ...
J&J's DePuy loses hip implant suit [Published PharmaGossip - Mar 09 2013] Jury says hip device defective, but no malice foundGREG RISLING \| Associated PressLOS ANGELES – A jury Friday awarded $8.3 million to a former prison guard who accused Johnson & Johnson’s DePuy Orthopaedics subsidiary of knowingly marketing a faulty hip ...
Should Investors Be Scared About This Johnson &... [Published Wall St. Cheat Sheet - Feb 25 2013] Johnson & Johnson ( NYSE:JNJ ) revealed it is the target of two separate government probes in its annual regulatory report to the Securities and Exchange Commission on Friday. One federal probe is related to the ASR XL hip device, which was recalled ...

Press Releases

sort by: Date \| Relevance
PROS Holdings, Inc. Reports First Quarter 2013 ... [Published Business Wire - May 02 2013]
Research and Markets: Synthes Inc.- Company Pro... [Published Business Wire Professional Services News - Apr 19 2013]
Research and Markets: Synthes Inc.- Company Pro... [Published Business Wire Health News - Apr 19 2013]
Research and Markets: DePuy Synthes Inc. 2013 C... [Published Business Wire Health News - Apr 17 2013]
Research and Markets: Global Bio-implants Marke... [Published Business Wire Health News - Mar 27 2013]